IP Library Granted Patent US 7,741,021
Granted Patent B2
US 7,741,021 · App. 11/595,319 · Granted Jun 22, 2010

Protein O-sulfonation

Assignees: Regents of the University of California; Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,741,021
App. No.
11/595,319
Granted
Jun 22, 2010
Kind
B2
Abstract

Post-translational O-sulfonation of a serine or threonine residue of proteins is detected, optionally comparatively, wherein the detected O-sulfonation is detected under a first physiological condition, and is compared with a control O-sulfonation detected under a second physiological condition, and a difference between the detected and control O-sulfonations indicates a difference between the first and second physiological conditions. Predetermined changes in physiological conditions are used to infer specific changes in O-sulfonation. Proteins are modified by introducing a predetermined change in O-sulfonation at a serine or threonine residue of the protein, and optionally, detecting a resultant change in O-sulfonation. These methods include introducing or increasing O-sulfonation, eliminating or reducing O-sulfonation; and derivatizing or substituting O-sulfonation.

Claims (13)

1. A method of modifying an isolated endogenous protein expressed by a cell, said method comprising the steps of:

transforming the sulfoserine or sulfothreonine residue of the isolated endogenous protein into a lysine isostere that is aminoethylcysteine or beta-methylaminoethylcysteine, respectively, by a beta-elimination followed by Michael's addition, thereby modifying the isolated endogenous protein,

wherein the cell is cultured to produce the endogenous protein comprising the sulfoserine or sulfothreonine residue as a result of a post-translational modification in said cell,

wherein the endogenous protein is isolated from the cell,

and

wherein endogenous means the protein is expressed by the cell.

2. The method of claim 1 further comprising the subsequent step of:

selectively cleaving the endogenous protein or a peptide thereof comprising the lysine isostere with a lysine specific protease.

3. The method of claim 1 further comprising the prior step of:

identifying a serine or threonine residue of the endogenous protein as subject to O-sulfonation in the cell, wherein the serine or threonine residue becomes the sulfoserine or sulfothreonine residue through O-sulfonation.

4. The method of claim 1 further comprising the subsequent step of:

selectively cleaving the endogenous protein or a peptide thereof comprising the lysine isostere with a lysine specific protease; and the prior step of:

identifying a serine or threonine residue of the endogenous protein as subject to O-sulfonation in the cell, wherein the serine or threonine residue becomes the sulfoserine or sulfothreonine residue through O-sulfonation.

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 2, 2018
From: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
To: NIH-DEITR
Reel/Frame 047037/0210 →
Continuity (2)
Continuation 1065702700 · Sep 5, 2003
Related Publication 20070059771A1 · Mar 15, 2007